Sciencast Management LP Takes $242,000 Position in Markel Corporation (MKL)

Sciencast Management LP bought a new stake in shares of Markel Corporation (NYSE:MKL) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 248 shares of the insurance provider’s stock, valued at approximately $242,000.

Several other large investors have also bought and sold shares of MKL. Vanguard Group Inc. grew its position in shares of Markel Corporation by 2.6% during the 2nd quarter. Vanguard Group Inc. now owns 1,129,189 shares of the insurance provider’s stock valued at $1,101,931,000 after acquiring an additional 28,104 shares during the period. Marathon Asset Management LLP grew its position in shares of Markel Corporation by 177.7% during the 2nd quarter. Marathon Asset Management LLP now owns 39,013 shares of the insurance provider’s stock valued at $38,066,000 after acquiring an additional 24,962 shares during the period. Principal Financial Group Inc. grew its position in shares of Markel Corporation by 3.7% during the 2nd quarter. Principal Financial Group Inc. now owns 659,167 shares of the insurance provider’s stock valued at $643,254,000 after acquiring an additional 23,417 shares during the period. Victory Capital Management Inc. grew its position in shares of Markel Corporation by 14.9% during the 2nd quarter. Victory Capital Management Inc. now owns 152,757 shares of the insurance provider’s stock valued at $149,069,000 after acquiring an additional 19,799 shares during the period. Finally, Bares Capital Management Inc. grew its position in shares of Markel Corporation by 18.2% during the 1st quarter. Bares Capital Management Inc. now owns 116,582 shares of the insurance provider’s stock valued at $113,768,000 after acquiring an additional 17,922 shares during the period. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Shares of Markel Corporation (NYSE:MKL) opened at 1091.275 on Wednesday. Markel Corporation has a 12-month low of $811.05 and a 12-month high of $1,094.99. The company has a 50-day moving average price of $1,051.84 and a 200 day moving average price of $1,004.87. The firm has a market capitalization of $15.18 billion, a PE ratio of 37.734 and a beta of 1.03.

Markel Corporation (NYSE:MKL) last issued its earnings results on Wednesday, July 26th. The insurance provider reported $9.94 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $6.27 by $3.67. Markel Corporation had a net margin of 7.58% and a return on equity of 4.81%. The company had revenue of $1.46 billion during the quarter, compared to analysts’ expectations of $1.46 billion. On average, equities analysts expect that Markel Corporation will post $27.56 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This article was originally reported by Markets Daily and is owned by of Markets Daily. If you are accessing this article on another website, it was illegally copied and republished in violation of U.S. and international copyright and trademark law. The original version of this article can be accessed at https://www.themarketsdaily.com/2017/10/11/sciencast-management-lp-takes-242000-position-in-markel-corporation-mkl.html.

MKL has been the topic of several research analyst reports. Boenning Scattergood set a $1,050.00 price objective on Markel Corporation and gave the stock a “buy” rating in a report on Wednesday, July 26th. ValuEngine upgraded Markel Corporation from a “sell” rating to a “hold” rating in a report on Tuesday, August 1st. Royal Bank Of Canada reiterated a “hold” rating and issued a $1,050.00 price objective on shares of Markel Corporation in a report on Tuesday, October 3rd. BidaskClub upgraded Markel Corporation from a “hold” rating to a “buy” rating in a report on Thursday, August 3rd. Finally, Zacks Investment Research cut Markel Corporation from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $1,050.00.

In other news, Vice Chairman Steven A. Markel sold 3,875 shares of the stock in a transaction that occurred on Tuesday, August 1st. The shares were sold at an average price of $1,074.48, for a total value of $4,163,610.00. Following the sale, the insider now directly owns 109,650 shares in the company, valued at $117,816,732. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Alan I. Kirshner sold 100 shares of the stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $1,054.03, for a total transaction of $105,403.00. Following the completion of the sale, the insider now owns 25,555 shares in the company, valued at $26,935,736.65. The disclosure for this sale can be found here. Insiders sold 6,027 shares of company stock worth $6,438,990 over the last quarter. Company insiders own 2.53% of the company’s stock.

Markel Corporation Company Profile

Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.

Want to see what other hedge funds are holding MKL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Markel Corporation (NYSE:MKL).

Institutional Ownership by Quarter for Markel Corporation (NYSE:MKL)

Receive News & Ratings for Markel Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply